Joswig, Holger https://orcid.org/0000-0003-3540-3910
Lichtenauer, Urs
Renken-Olthoff, Ilona
Schenk, Olaf
Wulfhorst, Britta
Funding for this research was provided by:
HMU Health and Medical University Potsdam GmbH
Article History
Received: 1 November 2025
Accepted: 21 March 2026
First Online: 27 March 2026
Declarations
:
: Prof. Dr. Holger Joswig accepted research as well as travel grants from Miethke, Nevro and Medtronic unrelated to this study. Ilona Renken-Olthoff is the CEO of all medical schools involved in this study and like the other authors, declares no conflicts of interest.
: Perplexity AI was used to improve English grammar of the final draft beforesubmission without changing the content.